The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Vascular Technology sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Vascular Technology Inc (VTI) is a medical equipment company that develops, manufactures and markets surgical devices. The company’s products include intraoperative doppler systems, OEM doppler applications, oxygen monitors and sensors, and suction products. Its doppler systems are used by vascular surgeonswhen performing a bypass graft to verify flow in an anastomosis and to locate vessels in scar tissue. VTI offers oxygen monitors that provide multipurpose oxygen monitoring system that employs membrane switch technology and integrated circuitry. The company’s products are used in the areas of micro-vascular surgery, urological surgery, vascular and GI endoscopy, neurological and spine. VTI is headquartered in Nashua, New Hampshire, the US.
The key metrics of Vascular Technology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Vascular Technology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Vascular Technology.
For a detailed understanding of the performance of Vascular Technology, buy the report here.